FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2081019225> ?p ?o ?g. }

• W2081019225 abstract "The NCIC CTG LY.12 study showed that gemcitabine, dexamethasone, and cisplatin (GDP) were noninferior to dexamethasone, cytarabine, and cisplatin (DHAP) in patients with relapsed or refractory aggressive histology lymphoma prior to autologous stem cell transplantation. We conducted an economic evaluation from the perspective of the Canadian public healthcare system based on trial data. The primary outcome was an incremental cost utility analysis comparing costs and benefits associated with GDP vs DHAP. Resource utilization data were collected from 519 Canadian patients in the trial. Costs were presented in 2012 Canadian dollars and disaggregated to highlight the major cost drivers of care. Benefit was measured as quality-adjusted life-years (QALYs) based on utilities translated from prospectively collected quality-of-life data. All statistical tests were two-sided. The mean overall costs of treatment per patient in the GDP and DHAP arms were $19 961 (95% confidence interval (CI) = $17 286 to $24 565) and $34 425 (95% CI = $31 901 to $39 520), respectively, with an incremental difference in direct medical costs of $14 464 per patient in favor of GDP (P < .001). The predominant cost driver for both treatment arms was related to hospitalizations. The mean discounted quality-adjusted overall survival with GDP was 0.161 QALYs and 0.152 QALYs for DHAP (difference = 0.01 QALYs, P = .146). In probabilistic sensitivity analysis, GDP was associated with both cost savings and improved quality-adjusted outcomes compared with DHAP in 92.6% of cost-pair simulations. GDP was associated with both lower costs and similar quality-adjusted outcomes compared with DHAP in patients with relapsed or refractory lymphoma. Considering both costs and outcomes, GDP was the dominant therapy." @default.
• W2081019225 created "2016-06-24" @default.
• W2081019225 creator A5001538581 @default.
• W2081019225 creator A5006619488 @default.
• W2081019225 creator A5008801653 @default.
• W2081019225 creator A5011619265 @default.
• W2081019225 creator A5012549313 @default.
• W2081019225 creator A5020540368 @default.
• W2081019225 creator A5024269299 @default.
• W2081019225 creator A5027397937 @default.
• W2081019225 creator A5032098740 @default.
• W2081019225 creator A5037155506 @default.
• W2081019225 creator A5058947386 @default.
• W2081019225 creator A5061856914 @default.
• W2081019225 creator A5062545920 @default.
• W2081019225 creator A5067291402 @default.
• W2081019225 creator A5079676031 @default.
• W2081019225 creator A5084106258 @default.
• W2081019225 creator A5085766162 @default.
• W2081019225 creator A5086588458 @default.
• W2081019225 creator A5088976216 @default.
• W2081019225 creator A5091222951 @default.
• W2081019225 date "2015-04-13" @default.
• W2081019225 modified "2023-10-16" @default.
• W2081019225 title "Gemcitabine/Dexamethasone/Cisplatin vs Cytarabine/Dexamethasone/Cisplatin for Relapsed or Refractory Aggressive-Histology Lymphoma: Cost-Utility Analysis of NCIC CTG LY.12" @default.
• W2081019225 cites W1834370350 @default.
• W2081019225 cites W197652455 @default.
• W2081019225 cites W1978861935 @default.
• W2081019225 cites W1997353354 @default.
• W2081019225 cites W2002055673 @default.
• W2081019225 cites W2022333024 @default.
• W2081019225 cites W2036392798 @default.
• W2081019225 cites W2044612846 @default.
• W2081019225 cites W2061836677 @default.
• W2081019225 cites W2106152781 @default.
• W2081019225 cites W2131789668 @default.
• W2081019225 cites W2133345449 @default.
• W2081019225 cites W2143532751 @default.
• W2081019225 cites W2150587745 @default.
• W2081019225 cites W2159637920 @default.
• W2081019225 cites W2224360697 @default.
• W2081019225 cites W2333359669 @default.
• W2081019225 cites W76549738 @default.
• W2081019225 doi "https://doi.org/10.1093/jnci/djv106" @default.
• W2081019225 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25868579" @default.
• W2081019225 hasPublicationYear "2015" @default.
• W2081019225 type Work @default.
• W2081019225 sameAs 2081019225 @default.
• W2081019225 citedByCount "19" @default.
• W2081019225 countsByYear W20810192252015 @default.
• W2081019225 countsByYear W20810192252016 @default.
• W2081019225 countsByYear W20810192252017 @default.
• W2081019225 countsByYear W20810192252019 @default.
• W2081019225 countsByYear W20810192252020 @default.
• W2081019225 countsByYear W20810192252021 @default.
• W2081019225 countsByYear W20810192252023 @default.
• W2081019225 crossrefType "journal-article" @default.
• W2081019225 hasAuthorship W2081019225A5001538581 @default.
• W2081019225 hasAuthorship W2081019225A5006619488 @default.
• W2081019225 hasAuthorship W2081019225A5008801653 @default.
• W2081019225 hasAuthorship W2081019225A5011619265 @default.
• W2081019225 hasAuthorship W2081019225A5012549313 @default.
• W2081019225 hasAuthorship W2081019225A5020540368 @default.
• W2081019225 hasAuthorship W2081019225A5024269299 @default.
• W2081019225 hasAuthorship W2081019225A5027397937 @default.
• W2081019225 hasAuthorship W2081019225A5032098740 @default.
• W2081019225 hasAuthorship W2081019225A5037155506 @default.
• W2081019225 hasAuthorship W2081019225A5058947386 @default.
• W2081019225 hasAuthorship W2081019225A5061856914 @default.
• W2081019225 hasAuthorship W2081019225A5062545920 @default.
• W2081019225 hasAuthorship W2081019225A5067291402 @default.
• W2081019225 hasAuthorship W2081019225A5079676031 @default.
• W2081019225 hasAuthorship W2081019225A5084106258 @default.
• W2081019225 hasAuthorship W2081019225A5085766162 @default.
• W2081019225 hasAuthorship W2081019225A5086588458 @default.
• W2081019225 hasAuthorship W2081019225A5088976216 @default.
• W2081019225 hasAuthorship W2081019225A5091222951 @default.
• W2081019225 hasBestOaLocation W20810192251 @default.
• W2081019225 hasConcept C112930515 @default.
• W2081019225 hasConcept C126322002 @default.
• W2081019225 hasConcept C143998085 @default.
• W2081019225 hasConcept C181199279 @default.
• W2081019225 hasConcept C185592680 @default.
• W2081019225 hasConcept C2776694085 @default.
• W2081019225 hasConcept C2779617269 @default.
• W2081019225 hasConcept C2780258809 @default.
• W2081019225 hasConcept C3019080777 @default.
• W2081019225 hasConcept C55493867 @default.
• W2081019225 hasConcept C64332521 @default.
• W2081019225 hasConcept C71924100 @default.
• W2081019225 hasConceptScore W2081019225C112930515 @default.
• W2081019225 hasConceptScore W2081019225C126322002 @default.
• W2081019225 hasConceptScore W2081019225C143998085 @default.
• W2081019225 hasConceptScore W2081019225C181199279 @default.
• W2081019225 hasConceptScore W2081019225C185592680 @default.
• W2081019225 hasConceptScore W2081019225C2776694085 @default.
• W2081019225 hasConceptScore W2081019225C2779617269 @default.
• W2081019225 hasConceptScore W2081019225C2780258809 @default.
• W2081019225 hasConceptScore W2081019225C3019080777 @default.
• W2081019225 hasConceptScore W2081019225C55493867 @default.

• next